Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease.

Journal of neurology - 1 Jan 2023

Periñán María Teresa, Macías-García Daniel, Jesús Silvia, Martín-Rodríguez Juan Francisco, Muñoz-Delgado Laura, Jimenez-Jaraba Maria Valle, Buiza-Rueda Dolores, Bonilla-Toribio Marta, Adarmes-Gómez Astrid Daniela, Gómez-Garre Pilar, Mir Pablo

Abstract excerpt

BACKGROUND: Hyperhomocysteinemia is considered an independent risk factor for cognitive impairment. OBJECTIVE: To study the correlation between homocysteine levels and cognitive impairment in patients with PD. METHODS: We conducted a case-control study that included 246 patients with PD, of whom 32 were cognitively impaired. The levels of homocysteine, folate, and vitamin B12 were measured in peripheral blood....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Cognitive Dysfunction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Folic Acid

Share to Genetic Background

Share to Homocysteine

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Parkinson Disease

Share to Vitamin B 12

Source

Identifiers

PMID: 36169739
DOI: 10.1007/s00415-022-11361-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease.PMID 36169739Read ↗

Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic studySemantic proximity Read ↗

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson's disease: a meta-analysis.Semantic proximity Read ↗

Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.Semantic proximity Read ↗

Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson's disease.Semantic proximity Read ↗

Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment.Semantic proximity Read ↗

Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients.Semantic proximity Read ↗

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.Semantic proximity Read ↗

Association of MTHFR, MTR, and MTRR polymorphisms with Parkinson's disease among ethnic Chinese in Taiwan.Semantic proximity Read ↗

MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.Semantic proximity Read ↗

Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.